Trial intelligence / Profile preview

Early intravenous metoprolol before reperfusion in STEMI planned for primary PCI

NL-OMON41647Phase 3Active, not recruiting

Sponsor
Isala
Start
Feb 2012
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised trial in myocardial infarction (MI) comparing Early intravenous metoprolol with Placebo (2 arms). Primary endpoint: Infarct size by MRI at 1 month. Started Feb 2012; status: active, not recruiting.

02

Drugs

metoprolol
03

Conditions

myocardial infarction (MI)

Beyond the preview

Go deeper on NL-OMON41647.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON41647.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call